194 related articles for article (PubMed ID: 22928011)
1. XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt.
Shiozaki A; Shen-Tu G; Bai X; Iitaka D; De Falco V; Santoro M; Keshavjee S; Liu M
PLoS One; 2012; 7(8):e43646. PubMed ID: 22928011
[TBL] [Abstract][Full Text] [Related]
2. XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.
Lodyga M; De Falco V; Bai XH; Kapus A; Melillo RM; Santoro M; Liu M
Oncogene; 2009 Feb; 28(7):937-49. PubMed ID: 19060924
[TBL] [Abstract][Full Text] [Related]
3. XB130, a novel adaptor protein, promotes thyroid tumor growth.
Shiozaki A; Lodyga M; Bai XH; Nadesalingam J; Oyaizu T; Winer D; Asa SL; Keshavjee S; Liu M
Am J Pathol; 2011 Jan; 178(1):391-401. PubMed ID: 21224076
[TBL] [Abstract][Full Text] [Related]
4. Roles of XB130, a novel adaptor protein, in cancer.
Shiozaki A; Liu M
J Clin Bioinforma; 2011 Mar; 1(1):10. PubMed ID: 21884627
[TBL] [Abstract][Full Text] [Related]
5. XB130/Tks5 scaffold protein interaction regulates Src-mediated cell proliferation and survival.
Moodley S; Hui Bai X; Kapus A; Yang B; Liu M
Mol Biol Cell; 2015 Dec; 26(24):4492-502. PubMed ID: 26446840
[TBL] [Abstract][Full Text] [Related]
6. XB130, a novel adaptor protein for signal transduction.
Xu J; Bai XH; Lodyga M; Han B; Xiao H; Keshavjee S; Hu J; Zhang H; Yang BB; Liu M
J Biol Chem; 2007 Jun; 282(22):16401-12. PubMed ID: 17412687
[TBL] [Abstract][Full Text] [Related]
7. Adaptor protein XB130 is a Rac-controlled component of lamellipodia that regulates cell motility and invasion.
Lodyga M; Bai XH; Kapus A; Liu M
J Cell Sci; 2010 Dec; 123(Pt 23):4156-69. PubMed ID: 21084565
[TBL] [Abstract][Full Text] [Related]
8. XB130 promotes bronchioalveolar stem cell and Club cell proliferation in airway epithelial repair and regeneration.
Toba H; Wang Y; Bai X; Zamel R; Cho HR; Liu H; Lira A; Keshavjee S; Liu M
Oncotarget; 2015 Oct; 6(31):30803-17. PubMed ID: 26360608
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of XB130 adaptor protein mediates trastuzumab resistance in gastric cancer.
Yang S; Wang B; Liao J; Hong Z; Zhong X; Chen S; Wu Z; Zhang X; Zuo Q
Clin Transl Oncol; 2023 Mar; 25(3):685-695. PubMed ID: 36284062
[TBL] [Abstract][Full Text] [Related]
10. The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.
Pelicci G; Troglio F; Bodini A; Melillo RM; Pettirossi V; Coda L; De Giuseppe A; Santoro M; Pelicci PG
Mol Cell Biol; 2002 Oct; 22(20):7351-63. PubMed ID: 12242309
[TBL] [Abstract][Full Text] [Related]
11. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
12. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
13. XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.
Shiozaki A; Kosuga T; Ichikawa D; Komatsu S; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Shimizu H; Ishimoto T; Kitagawa M; Nakou Y; Kishimoto M; Liu M; Otsuji E
Ann Surg Oncol; 2013 Sep; 20(9):3140-50. PubMed ID: 22805860
[TBL] [Abstract][Full Text] [Related]
14. LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β.
Zhao WJ; Zhu LL; Yang WQ; Xu SJ; Chen J; Ding XF; Liang Y; Chen G
Cancer Sci; 2021 Apr; 112(4):1624-1632. PubMed ID: 33540491
[TBL] [Abstract][Full Text] [Related]
15. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
16. XB130 is overexpressed in prostate cancer and involved in cell growth and invasion.
Chen B; Liao M; Wei Q; Liu F; Zeng Q; Wang W; Liu J; Hou J; Yu X; Liu J
Oncotarget; 2016 Sep; 7(37):59377-59387. PubMed ID: 27509056
[TBL] [Abstract][Full Text] [Related]
17. RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors.
De Falco V; Guarino V; Malorni L; Cirafici AM; Troglio F; Erreni M; Pelicci G; Santoro M; Melillo RM
Oncogene; 2005 Sep; 24(41):6303-13. PubMed ID: 15940252
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
[TBL] [Abstract][Full Text] [Related]
19. XB130 enhances invasion and migration of human colorectal cancer cells by promoting epithelial‑mesenchymal transition.
Shen J; Jin C; Liu Y; Rao H; Liu J; Li J
Mol Med Rep; 2017 Oct; 16(4):5592-5598. PubMed ID: 28849225
[TBL] [Abstract][Full Text] [Related]
20. The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway.
Liu R; Liu D; Trink E; Bojdani E; Ning G; Xing M
J Clin Endocrinol Metab; 2011 Apr; 96(4):E577-85. PubMed ID: 21289267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
